283 related articles for article (PubMed ID: 16391156)
21. Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily.
Hartung R; Matzkin H; Alcaraz A; Emberton M; Harving N; van Moorselaar J; Elhilali M; Vallancien G;
J Urol; 2006 Feb; 175(2):624-8; discussion 628. PubMed ID: 16407011
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001.
Choi KM; Park HS; Han JH; Lee JS; Lee J; Ryu OH; Lee KW; Cho KH; Yoon D; Baik SH; Choi DS; Kim SM
J Hypertens; 2006 Aug; 24(8):1515-21. PubMed ID: 16877953
[TBL] [Abstract][Full Text] [Related]
23. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994.
Paulose-Ram R; Jonas BS; Orwig D; Safran MA
J Clin Epidemiol; 2004 Mar; 57(3):309-17. PubMed ID: 15066692
[TBL] [Abstract][Full Text] [Related]
24. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
[TBL] [Abstract][Full Text] [Related]
25. Differences in need for antihypertensive drugs among those aware and unaware of their hypertensive status: a cross sectional survey.
Khan NA; Wardman D; Campbell NR
BMC Cardiovasc Disord; 2005 Feb; 5(1):4. PubMed ID: 15691376
[TBL] [Abstract][Full Text] [Related]
26. Effect of treatment and adherence on ethnic differences in blood pressure control among adults with hypertension.
Natarajan S; Santa Ana EJ; Liao Y; Lipsitz SR; McGee DL
Ann Epidemiol; 2009 Mar; 19(3):172-9. PubMed ID: 19216999
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive medication adherence in the Department of Veterans Affairs.
Siegel D; Lopez J; Meier J
Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
[TBL] [Abstract][Full Text] [Related]
28. Managing hypertension using combination therapy.
Frank J
Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
30. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
[TBL] [Abstract][Full Text] [Related]
31. Choice of first antihypertensive: simple as ABCD?
Mahmud A; Feely J
Am J Hypertens; 2007 Aug; 20(8):923-7. PubMed ID: 17679044
[TBL] [Abstract][Full Text] [Related]
32. Hypertension control at physicians' offices in the United States.
Fang J; Alderman MH; Keenan NL; Ayala C; Croft JB
Am J Hypertens; 2008 Feb; 21(2):136-42. PubMed ID: 18188159
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive prescriptions over a 10-year period in a large Chinese population.
Wong MC; Tam WW; Cheung CS; Tong EL; Sek AC; Cheung NT; Yan BP; Yu CM; Griffiths SM
Am J Hypertens; 2013 Jul; 26(7):931-8. PubMed ID: 23591987
[TBL] [Abstract][Full Text] [Related]
34. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
35. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
36. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
Furtado C; Pinto M
Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
[TBL] [Abstract][Full Text] [Related]
37. Uncontrolled blood pressure in a treated, high-risk managed care population.
Andros V
Am J Manag Care; 2005 Sep; 11(7 Suppl):S215-9. PubMed ID: 16180959
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure control in patients initiating antihypertensive therapy.
Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
[TBL] [Abstract][Full Text] [Related]
39. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
40. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States.
Ezzati M; Oza S; Danaei G; Murray CJ
Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]